OBJECTIVE: Although universal antenatal HIV screening identifies most women with HIV, women who are exposed to HIV and seroconvert during pregnancy remain at risk of not being identified. These women are at significantly increased risk of maternal-to-child transmission (MTCT). Implementation of male partner HIV testing in routine prenatal care has not previously been evaluated in the United States. The objective was to assess interest in and uptake of partner HIV testing services as well as characteristics associated with each. STUDY DESIGN: This quality improvement demonstration project included all pregnant English-speaking HIV-negative women receiving publicly funded prenatal care in a single hospital-based practice located in a high HIV prevalence urban center. Women were offered free HIV screening for their male sexual partners. From April 2017 to June 2018, enrolled women completed surveys on sociodemographic and medical access characteristics as well as HIV testing history and preferences. Women were invited to bring their partners to a prenatal visit where pre-test counseling was provided and HIV testing offered. Factors associated with pregnant women's interest in having their partner tested and completion of partner testing were assessed. RESULTS: Of 392 women approached, 70% (N¼274) completed study surveys. Although the majority (73%, N¼200) of women desired their partner undergo HIV testing, only 18 (7%) of the partners of women who enrolled ultimately completed HIV testing ( Figure) . Maternal sociodemographic characteristics (age, race/ ethnicity, parity, number of current sexual partners, educational, employment, and marital status) were not associated with interest in or completion of partner HIV testing. Similarly, HIV testing history, testing preferences, and medical access characteristics were not significantly associated with interest in or uptake of partner testing services (Table) . CONCLUSION: Male partner HIV testing has the potential for primary HIV prevention and may be especially critical during pregnancy. Although the majority of low income women in an urban prenatal clinic expressed interest in having their partner tested, uptake of the free HIV testing services was uncommon. A focused assessment of implementation barriers is needed to optimize partner testing and eliminate HIV transmission to mothers and their babies. 
The association between polyhydramnios and CMV infection

OBJECTIVE:
The window of opportunity to treat congenital CMV is narrow and therefore CMV infection should be tested early when risk factors arise., It has been suggested that polyhydramnios is associated with CMV infection, resulting in polyhydramnios being the most common indication for CMV testing. Possible mechanisms include impaired swallowing due to CNS injury, polyuria via renal infection, and fetal malformations. However, this subject was examined only in small studies with methodological limitations that failed to demonstrate a clear association between polyhydramnios and CMV infection. We aimed to examine the association between congenital CMV infection and polyhydramnios. STUDY DESIGN: A retrospective cross-sectional cohort study was conducted between January 2013 and December 2017. In our center polyhydramnios is not an indication for CMV testing. The rate of polyhydramnios was analyzed in 61 neonates and 2 fetuses that tested positive for CMV infection between 2013 and 2017 and compared to 351 neonates who tested negative to CMV using PCR targeted to the viral DNA. The rate of oligohydramnios and small for gestational age was also evaluated. The sample size was calculated assuming that the rate of polyhydramnios is 2% versus 10% in the negative and positive CMV infection groups, respectively (80% power, 5% 2-sided alpha). RESULTS: The indications for CMV testing are presented in the figure. Study characteristics and outcomes are presented in the table. No statistically significant difference in the rate of polyhydramnios, oligohydramnios or small for gestational age neonate was found in fetuses/neonates with and without congenital CMV. There were no cases of polyhydramnios combined with fetal malformations. CONCLUSION: The results of this study do not support an association between CMV infection and polyhydramnios. The need for antenatal or postnatal CMV testing in isolated polyhydramnios should be reevaluated.
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